Similar articles

• Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy.

  Koski CL, Baumgarten M, Magder LS, Barohn RJ, Goldstein J, Graves M, Gorson K, Hahn AF, Hughes RA, Katz J, Lewis RA, Parry GJ, van Doorn P, Cornblath DR. Koski CL, et al. J Neurol Sci. 2009 Feb 15;277(1-2):1-8. doi: 10.1016/j.jns.2008.11.015. Epub 2008 Dec 16. J Neurol Sci. 2009. PMID: 19091330
• Chronic inflammatory demyelinating polyneuropathy: a treatment protocol proposal.

  Odaka M. Odaka M. Expert Rev Neurother. 2006 Mar;6(3):365-79. doi: 10.1586/14737175.6.3.365. Expert Rev Neurother. 2006. PMID: 16533141 Review.
• Chronic inflammatory demyelinating polyradiculoneuropathy: new views and guidelines.

  Donofrio PD. Donofrio PD. J Peripher Nerv Syst. 2005 Sep;10(3):217-9. doi: 10.1111/j.1085-9489.2005.10301.x. J Peripher Nerv Syst. 2005. PMID: 16221282 No abstract available.
• Comment on European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy.

  Latov N. Latov N. J Peripher Nerv Syst. 2006 Mar;11(1):88-9; author reply 90-1. doi: 10.1111/j.1085-9489.2006.00068.x. J Peripher Nerv Syst. 2006. PMID: 16519787 No abstract available.
• Diagnostic and therapeutic challenges in chronic inflammatory demyelinating polyneuropathy and other immune-mediated neuropathies.

  Magy L, Mathis S, Vallat JM. Magy L, et al. Curr Opin Crit Care. 2011 Apr;17(2):101-5. doi: 10.1097/MCC.0b013e328342aded. Curr Opin Crit Care. 2011. PMID: 21157311 Review.